Literature DB >> 20075571

The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses.

Atsuhisa Tamura1, Masahiro Shimada, Yoshinori Matsui, Masahiro Kawashima, Junko Suzuki, Haruyuki Ariga, Nobuharu Ohshima, Kimihiko Masuda, Hirotoshi Matsui, Hideaki Nagai, Naohiro Nagayama, Emiko Toyota, Shinobu Akagawa, Akira Hebisawa.   

Abstract

OBJECTIVE: This study assessed the diagnostic rate of pulmonary tuberculosis (PTB) using fiberoptic bronchoscopy (FBS) in patients with suspected PTB, and negative pre-bronchoscopy smear and polymerase-chain reaction (PCR) in sputum. PATIENTS AND METHODS: We retrospectively reviewed 201 culture-positive PTB patients that underwent FBS because both smear and PCR results in sputum were negative. The positive rates of smear for acid fast bacilli, PCR for Mycobacterium tuberculosis, the presence of granuloma in transbronchial biopsy (TBB), and culture of M. tuberculosis were analyzed. In addition, the radiographic features, contribution of FBS to rapid and/or definitive diagnosis of PTB, and drug susceptibility results of M. tuberculosis were also reviewed.
RESULTS: There were 136 males and 102 patients under the age of 40 years; non-cavitary (156 cases) and minimal disease (119 cases) on radiographs predominated. The positive rates of FBS were: 44% (smear), 62% (PCR), 61% (TBB), and 87% (culture). These rates increased in smear and PCR examinations when taken from wider spread shadows on radiographs. The combination of the various bronchoscopy samples increased the diagnostic rate to 92% when all examinations were combined. Positive culture results depended on FBS procedures in 80 cases. Twenty-one cases showed resistance to at least one of the major anti-tuberculous agents.
CONCLUSION: This analysis revealed high positive rates of PTB from bronchoscopy samples, providing rapid and definitive ability for PTB diagnosis, and details of drug susceptibility. Therefore, FBS is an important diagnostic procedure in patients with suspected PTB whose sputum specimens were negative both for smear and PCR analyses.

Entities:  

Mesh:

Year:  2010        PMID: 20075571     DOI: 10.2169/internalmedicine.49.2686

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  The Value of Bronchoalveolar Lavage in the Diagnosis of Sputum Smear-NegativePulmonary Tuberculosis.

Authors:  Novin Nikbakhsh; Masomeh Bayani; Sepideh Siadati
Journal:  Iran J Pathol       Date:  2015

2.  Diagnostic value of bronchoscopy in sputum-negative pulmonary tuberculosis patients and its correlation with clinicoradiological features.

Authors:  Sadia Imtiaz; Enas Mansour Batubara
Journal:  Ann Thorac Med       Date:  2022-04-19       Impact factor: 2.535

3.  The effectiveness of real-time PCR assay, compared with microbiologic results for the diagnosis of pulmonary tuberculosis.

Authors:  Seo Woo Kim; Sae In Kim; Seok Jeong Lee; Jin Hwa Lee; Yun Ju Ryu; Sung Shine Shim; Yookyoung Kim; Mi Ae Lee; Jung Hyun Chang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-01-29

4.  Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study.

Authors:  Yong Soo Kwon; Su Young Chi; In Jae Oh; Kyu Sik Kim; Yu Il Kim; Sung Chul Lim; Young Chul Kim
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

5.  Active case finding of tuberculosis (TB) in an emergency room in a region with high prevalence of TB in Brazil.

Authors:  Denise Rossato Silva; Alice Mânica Müller; Karina da Silva Tomasini; Paulo de Tarso Roth Dalcin; Jonathan E Golub; Marcus Barreto Conde
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

6.  Relationship Between Lung Cancer and Mycobacterium Avium Complex Isolated Using Bronchoscopy.

Authors:  Atsuhisa Tamura; Akira Hebisawa; Kei Kusaka; Takashi Hirose; Junko Suzuki; Akira Yamane; Hideaki Nagai; Takeshi Fukami; Ken Ohta; Fumiaki Takahashi
Journal:  Open Respir Med J       Date:  2016-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.